Ceftriaxone and Strabismus - a phase IV clinical study of FDA data

Summary:

Strabismus is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Ocrevus, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Strabismus when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Strabismus?

Strabismus (a disorder in which the two eyes do not line up in the same direction) is found to be associated with 344 drugs and 773 conditions by eHealthMe. Check the latest studies of Strabismus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 13 people (0.03%) have Strabismus.

Could Ceftriaxone cause Strabismus?

Among these 13 people:

How long have people been on Ceftriaxone when they have Strabismus? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Strabismus when taking Ceftriaxone? *

  • female: 37.5 %
  • male: 62.5 %

What is the age of people who have Strabismus when taking Ceftriaxone? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 16.67 %
  • 40-49: 16.67 %
  • 50-59: 16.67 %
  • 60+: 16.67 %

What are other drugs people take besides Ceftriaxone? *

  1. Solu-Medrol: 3 people, 23.08%
  2. Ocrevus: 3 people, 23.08%
  3. Augmentin: 2 people, 15.38%
  4. Cefixime: 2 people, 15.38%
  5. Prednisone: 2 people, 15.38%
  6. Flomax: 1 person, 7.69%
  7. Midazolam: 1 person, 7.69%
  8. Macrodantin: 1 person, 7.69%
  9. Lasix: 1 person, 7.69%
  10. Keppra: 1 person, 7.69%

What are other side effects people have besides Strabismus? *

  1. Nasopharyngitis (inflammation of the nasopharynx): 5 people, 38.46%
  2. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 4 people, 30.77%
  3. Premature Baby: 4 people, 30.77%
  4. Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 30.77%
  5. Eye Movements - Uncontrollable: 4 people, 30.77%
  6. Memory Loss: 4 people, 30.77%
  7. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 4 people, 30.77%
  8. Fever: 3 people, 23.08%
  9. Infection: 3 people, 23.08%
  10. Disturbance In Attention: 3 people, 23.08%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 30.77%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 15.38%
  3. Pneumonia: 2 people, 15.38%
  4. Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 7.69%
  5. Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 7.69%
  6. Septic Embolus (a type of embolism that is infected with bacteria): 1 person, 7.69%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
  8. Polyarthritis (arthritis which involves 5 or more joints simultaneously): 1 person, 7.69%
  9. Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon): 1 person, 7.69%
  10. Swelling Face: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Strabismus?

- Check whether Strabismus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:

Strabismus treatments and more:

How severe was Strabismus and when was it recovered:

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Strabismus:

Browse all the conditions that are associated with Strabismus:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: